{"id":"W4388666126","doi":"10.1016/j.jtocrr.2023.100601","title":"Real-World Immunotherapy Use and Effectiveness in Advanced NSCLC With Programmed Death-Ligand 1 Greater Than or Equal to 50% and Greater Than or Equal to 90%","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Sanofi; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pembrolizumab; Medicine; Internal medicine; Cohort; Oncology; PD-L1; Immunotherapy; Clinical endpoint; Chemotherapy; Population; Cancer; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005896901,0.0003245481,0.0008461602,0.0005367524,0.0002019144,0.0002063556,0.00009294976,0.0002095839,0.00003713235],"category_scores_gemma":[0.0008550206,0.0001734272,0.00009168559,0.001152604,0.0005115056,0.0001850891,0.0002223721,0.0005386564,0.000005366856],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009577323,"about_ca_system_score_gemma":0.0003486816,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00234504,"about_ca_topic_score_gemma":0.004273866,"domain_scores_codex":[0.9958121,0.0005301851,0.0008680453,0.001083404,0.000834248,0.0008720584],"domain_scores_gemma":[0.996982,0.001424047,0.0001088246,0.0005701805,0.0002812668,0.0006337314],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1021382,0.0002166491,0.815416,0.0002233197,0.0002401597,0.004934121,0.0007157847,7.014544e-7,0.004508834,0.000009335141,0.000286425,0.07131042],"study_design_scores_gemma":[0.006657854,0.008318732,0.969824,0.001149676,0.00003025755,0.0004161899,0.00022487,0.000009793876,0.002376237,0.0001162927,0.01056702,0.0003091088],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994607,0.0001603271,0.00003954323,0.001937306,0.0001515958,0.00290384,0.0000113297,0.00008659408,0.0001024162],"genre_scores_gemma":[0.9923015,0.001255965,0.0003410174,0.0003264199,0.0001619546,0.0005128831,0.00001640041,0.00006525266,0.005018603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.154408,"threshold_uncertainty_score":0.7072156,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.204960016965594,"score_gpt":0.4796957161427269,"score_spread":0.2747356991771329,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}